📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: SuppreMol

1.1 - Company Overview

SuppreMol Logo

SuppreMol

Headquarter: Germany
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of biotechnology therapies pioneering a novel approach to treat autoimmune diseases, aiming to cure these disorders rather than merely manage symptoms; privately held.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to SuppreMol

ImmuVen Logo

ImmuVen

HQ: United States Website
  • Description: Provider of biotherapeutic discovery and drug development for infectious diseases, cancer, and autoimmune disorders.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full ImmuVen company profile →
Eureka Therapeutics Logo

Eureka Therapeutics

HQ: United States Website
  • Description: Provider of T-cell therapies via the ARTEMIS Cell Receptor Platform to engineer T cells to target and destroy cancer cells; the E-ALPHA Phage Display Platform to generate specific antibodies against cancer targets, including TCR-mimic antibodies for solid tumors; and an Expanded Access Policy offering investigational cell therapy under certain conditions to patients with serious or life-threatening diseases who have no other treatment options.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Eureka Therapeutics company profile →
Nascent Biotech Logo

Nascent Biotech

HQ: United States Website
  • Description: Provider of therapeutic antibodies and platform technologies. Pritumumab is a natural human IgG antibody targeting ecto-domain vimentin on adenocarcinomas, including brain cancers and melanoma; MultiPharm is a multi-agent (antibodies and/or cytokines) platform for potential treatment of cancer, diabetes, autoimmunity, and transplantation; and CLNH5 is a patented technology with four patents awarded by the United States Patent Office.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Nascent Biotech company profile →
Dara Biosciences Logo

Dara Biosciences

HQ: United States Website
  • Description: Provider of oncology treatment and supportive care products, dedicated to commercialization as a specialty pharmaceutical company.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Dara Biosciences company profile →
Active Biotech Logo

Active Biotech

HQ: Sweden Website
  • Description: Provider of biotechnology research and development of pharmaceuticals and vaccines, based on knowledge of autoimmune/inflammatory diseases and cancer, developing products to treat conditions including multiple sclerosis and lung and renal diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Active Biotech company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for SuppreMol

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to SuppreMol

2.2 - Growth funds investing in similar companies to SuppreMol

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for SuppreMol

4.2 - Public trading comparable groups for SuppreMol

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to SuppreMol

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About SuppreMol

What does SuppreMol do?

SuppreMol is a provider of biotechnology therapies pioneering a novel approach to treat autoimmune diseases, aiming to cure these disorders rather than merely manage symptoms; privately held.

Who are SuppreMol's competitors?

SuppreMol's competitors and similar companies include ImmuVen, Eureka Therapeutics, Nascent Biotech, Dara Biosciences, and Active Biotech.

Where is SuppreMol headquartered?

SuppreMol is headquartered in Germany.

How many employees does SuppreMol have?

SuppreMol has 1,000 employees 🔒.

When was SuppreMol founded?

SuppreMol was founded in 2010 🔒.

What sector and industry vertical is SuppreMol in?

SuppreMol is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for SuppreMol

Who are the top strategic acquirers in SuppreMol's sector and industry

Top strategic M&A buyers and acquirers in SuppreMol's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for SuppreMol?

Top strategic M&A buyers groups and sectors for SuppreMol include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in SuppreMol's sector and industry vertical

Which are the top PE firms investing in SuppreMol's sector and industry vertical?

Top PE firms investing in SuppreMol's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in SuppreMol's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in SuppreMol's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in SuppreMol's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to SuppreMol include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in SuppreMol's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for SuppreMol?

The key public trading comparables and valuation benchmarks for SuppreMol include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for SuppreMol for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for SuppreMol with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in SuppreMol's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for SuppreMol with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in SuppreMol's' sector and industry vertical?

Access recent funding rounds and capital raises in SuppreMol's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for SuppreMol